Shelton Capital Management 10x Genomics, Inc. Transaction History

Shelton Capital Management

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$55.7 - $145.79 $1.08 Million - $2.81 Million	-19,300 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$145.58 - $192.14 $334,834 - $441,921	2,300 Added 13.53%	19,300 $2.81 Million
Q1 2021 May 14, 2021	BUY	$140.25 - $196.86 $701,250 - $984,300	5,000 Added 41.67%	17,000 $3.08 Million
Q4 2020 Feb 16, 2021	BUY	$126.47 - $163.7 $581,762 - $753,020	4,600 Added 62.16%	12,000 $1.7 Million
Q3 2020 Nov 09, 2020	BUY	$87.44 - $125.0 $647,056 - $925,000	7,400 New	7,400 $923,000

291

94.7M

263K

85.1K

Ticker TXG
Exchange NASDAQ
Sector Healthcare
Industry Health Information Services
Shares Outstandng 95,046,400
Market Cap $1.5B
Description
10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...

Get notified when there are updates to the investment portfolio of Shelton Capital Management, based on Form 13F filings with the SEC.

Stay updated on Shelton Capital Management with notifications on news.